These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adjuvants for vaccines to drugs of abuse and addiction. Alving CR; Matyas GR; Torres O; Jalah R; Beck Z Vaccine; 2014 Sep; 32(42):5382-9. PubMed ID: 25111169 [TBL] [Abstract][Full Text] [Related]
4. Polyphosphazene: A New Adjuvant Platform for Cocaine Vaccine Development. Lin M; Marin A; Ellis B; Eubanks LM; Andrianov AK; Janda KD Mol Pharm; 2022 Sep; 19(9):3358-3366. PubMed ID: 35984034 [TBL] [Abstract][Full Text] [Related]
5. Efficient Syntheses of Cocaine Vaccines and Their Kimishima A; Olson ME; Natori Y; Janda KD ACS Med Chem Lett; 2018 May; 9(5):411-416. PubMed ID: 29795751 [TBL] [Abstract][Full Text] [Related]
6. Hapten optimization for cocaine vaccine with improved cocaine recognition. Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171 [TBL] [Abstract][Full Text] [Related]
7. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs. Matyas GR; Mayorov AV; Rice KC; Jacobson AE; Cheng K; Iyer MR; Li F; Beck Z; Janda KD; Alving CR Vaccine; 2013 Jun; 31(26):2804-10. PubMed ID: 23624097 [TBL] [Abstract][Full Text] [Related]
8. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers. Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207 [TBL] [Abstract][Full Text] [Related]
9. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders. Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019 [TBL] [Abstract][Full Text] [Related]
15. Vaccination against cocaine using a modifiable dendrimer nanoparticle platform. Lowell JA; Dikici E; Joshi PM; Landgraf R; Lemmon VP; Daunert S; Izenwasser S; Daftarian P Vaccine; 2020 Nov; 38(50):7989-7997. PubMed ID: 33158592 [TBL] [Abstract][Full Text] [Related]
16. Investigations into the efficacy of multi-component cocaine vaccines. Kimishima A; Olson ME; Janda KD Bioorg Med Chem Lett; 2018 Sep; 28(16):2779-2783. PubMed ID: 29317163 [TBL] [Abstract][Full Text] [Related]
17. Vaccines against stimulants: cocaine and MA. Kosten T; Domingo C; Orson F; Kinsey B Br J Clin Pharmacol; 2014 Feb; 77(2):368-74. PubMed ID: 23509915 [TBL] [Abstract][Full Text] [Related]
18. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant. Longenecker BM; Reddish M; Koganty R; MacLean GD Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215 [TBL] [Abstract][Full Text] [Related]
19. A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity. Sato-Kaneko F; Yao S; Lao FS; Shpigelman J; Messer K; Pu M; Shukla NM; Cottam HB; Chan M; Chu PJ; Burkhart D; Schoener R; Matsutani T; Carson DA; Corr M; Hayashi T Front Immunol; 2020; 11():1207. PubMed ID: 32636840 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization. Kosten TA; Shen XY; Kinsey BM; Kosten TR; Orson FM Am J Addict; 2014; 23(6):604-7. PubMed ID: 25251469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]